120 related articles for article (PubMed ID: 32329840)
1. LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.
Chen GR; Sun W; Zheng K; Zhu W
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3648-3656. PubMed ID: 32329840
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
3. ETV4 promotes the progression of gastric cancer through regulating KDM5D.
Cai LS; Chen QX; Fang SY; Lian MQ; Lian MJ; Cai MZ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2442-2451. PubMed ID: 32196595
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA hsa_circ_103809 promotes cell migration and invasion of gastric cancer cells by binding to microRNA-101-3p.
Huang SS; Guo WX; Ren MS
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6064-6071. PubMed ID: 32572921
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway.
Chen QF; Hu CF; Sun K; Lang YP
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1324 inhibits cell proliferative ability and invasiveness by targeting MECP2 in gastric cancer.
Zhang XY; Xu YY; Chen WY
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4766-4774. PubMed ID: 32432740
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
10. LINC01296 promotes the proliferation and invasion by regulating microRNA-760 expression and predicts poor prognosis of hepatocellular carcinoma.
Wang ZC; Yang S; Chen MQ; Wu SS; Lv HH; Jin WX
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9848-9856. PubMed ID: 31799652
[TBL] [Abstract][Full Text] [Related]
11. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
He Y; Wu L; Dai Y; Li J; Liu S
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
Li H; Yuan R; Wang H; Li C; Wei J
J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
[TBL] [Abstract][Full Text] [Related]
15. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
Feng F; Chen AP; Wang XL; Wu GL
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
Wang GF; Wen LN
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
